Are Sin Stocks the Answer to Beating Inflation in 2022?
In a world where Environmental, Social and Governance (ESG) factors are playing an increasingly significant role in where investors place their money, the prospect of investing in sin stocks – such as alcohol and tobacco companies - may seem slightly taboo.
However, as inflation around the world runs red hot and central banks mull the prospect of interest rate hikes, so-called sin stocks meet many of the requirements which investors look for during such uncertain times.
So, what are these requirements? Whilst they will be different from investor to investor, we can highlight three things that most will be looking for in the current climate.
Firstly, and perhaps most importantly, investors are looking for reliable businesses which will perform well and continue to generate cash flow regardless of the overriding economic environment; they seek predictability amidst the uncertainty.
Secondly, as inflation rises so too do input costs for businesses, if a business cannot pass these rising costs onto the consumer, then their profits will be reduced. Investors, therefore, seek companies with strong pricing power who can raise prices if they need to.
Thirdly, stocks which pay a decent dividend are a huge plus. Inflation erodes the purchasing power of your money, regular dividend payments combined with capital growth work together to offset this impact.
Three requirements, three ticks for sin stocks.
Demand for the majority of products produced by sin stocks is inelastic. In other words, regardless of what is going on in the economy, people who are so inclined will continue to smoke and drink, and will weather almost any associated price rises which may come their way. Furthermore, thanks to the healthy cash flows associated with producing such products, many sin stocks are reliable and generous dividend payers.
Take British American Tobacco (BAT), for example, whose current dividend yield is 6.4%. Not only did the cigarette manufacturer recently increase its annual dividend, something which it has done for more than 20 years, but it also announced a $2 billion share buyback programme – a sign of a confident company with a strong cash flow.
Moreover, the tobacco stock has considerably outperformed the market so far this year, gaining more than 23% year to date compared with the FTSE 100’s 1.4% rise.
Sin stocks such as BAT could be poised to continue to benefit from a shift in investor behaviour this year and may prove to be a way for investors to beat inflation in 2022.
Of course, there are risks associated with investing in such companies. Continuing with the example of tobacco, the industry faces constantly changing regulatory requirements and increases in taxes and restrictions on their products. Additionally, the well-publicised detrimental health effects of cigarettes have successfully led to a decrease in the number of smokers around the world.
Depicted: Admiral Markets MetaTrader 5 – British American Tobacco (BATS) Daily Chart. Date Range: 20 October 2020 – 21 February 2022. Date Captured: 21 February 2022. Past performance is not a reliable indicator of future results.
Invest with Admiral Markets
With an Invest.MT5 account from Admiral Markets, you can buy shares in British American Tobacco and over 4,300 other listed companies from 15 of the largest stock exchanges in the world! Click the banner below in order to learn more and register for an account today:
INFORMATION ABOUT ANALYTICAL MATERIALS:
The given data provides additional information regarding all analysis, estimates, prognosis, forecasts, market reviews, weekly outlooks or other similar assessments or information (hereinafter “Analysis”) published on the websites of Admiral Markets investment firms operating under the Admiral Markets trademark (hereinafter “Admiral Markets”) Before making any investment decisions please pay close attention to the following:
- This is a marketing communication. The content is published for informative purposes only and is in no way to be construed as investment advice or recommendation. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and that it is not subject to any prohibition on dealing ahead of the dissemination of investment research.
- Any investment decision is made by each client alone whereas Admiral Markets shall not be responsible for any loss or damage arising from any such decision, whether or not based on the content.
- With view to protecting the interests of our clients and the objectivity of the Analysis, Admiral Markets has established relevant internal procedures for prevention and management of conflicts of interest.
- The Analysis is prepared by an independent analyst Roberto Rivero, Freelance Contributor (hereinafter "Author") based on personal estimations.
- Whilst every reasonable effort is taken to ensure that all sources of the content are reliable and that all information is presented, as much as possible, in an understandable, timely, precise and complete manner, Admiral Markets does not guarantee the accuracy or completeness of any information contained within the Analysis.
- Any kind of past or modelled performance of financial instruments indicated within the content should not be construed as an express or implied promise, guarantee or implication by Admiral Markets for any future performance. The value of the financial instrument may both increase and decrease and the preservation of the asset value is not guaranteed.
- Leveraged products (including contracts for difference) are speculative in nature and may result in losses or profit. Before you start trading, please ensure that you fully understand the risks involved.
